Age at Dx (years)
| | | |
59.7 (11.5), 25-93
|
Gender
|
Male
|
259
|
75 %
| |
|
Female
|
87
|
25 %
| |
Cancer Site
|
Larynx/Glottic
|
83
|
24 %
| |
|
Oral Cavity
|
126
|
36 %
| |
|
Oropharynx
|
125
|
36 %
| |
|
Hypopharynx
|
12
|
3 %
| |
Cancer Stage
|
I/Cis
|
47
|
14 %
| |
|
II
|
35
|
10 %
| |
|
III
|
52
|
15 %
| |
|
IV
|
212
|
61 %
| |
Comorbidities (ACE)
|
None
|
91
|
26 %
| |
|
Mild
|
158
|
46 %
| |
|
Moderate
|
70
|
20 %
| |
|
Severe
|
27
|
8 %
| |
HPV status
|
Positive
|
135
|
39 %
| |
|
Negative
|
211
|
61 %
| |
Tobacco Use
|
Current (within past 12 months)
|
145
|
42 %
| |
|
Former (quit > 12 months)
|
125
|
36 %
| |
|
Never
|
76
|
22 %
| |
Pack Years, n = 257
|
(cigs only)
| | |
35.6 (30.0), 0.1-171.0
|
Pack Years, n = 264
|
(sum of cigs, cigars, pipe)
| | |
37.7 (33.3), 0.07-242.9
|
Alcohol Use, n = 244
|
Never
|
29
|
8 %
| |
|
Former (quit >12 months)
|
227
|
66 %
| |
|
Current (within past 12 months)
|
90
|
26 %
| |
Treatment, n = 335
|
Surgery alone
|
67
|
20 %
| |
|
Radiation alone
|
34
|
10 %
| |
|
Surgery + Radiation
|
34
|
10 %
| |
|
Radiation + Chemotherapy
|
138
|
41 %
| |
|
Surgery + Radiation + Chemotherapy
|
39
|
12 %
| |
|
No Treatment prior to death
|
23
|
7 %
| |
Persistent Diseasea
| |
29
|
8 %
| |
Median Follow-up for Survival
| |
27 months
| | |
Median Follow-up for Recurrence/Persistence
| |
24 months
| | |
Recurrence/Persistenceb
| |
81
| | |
Death
| |
78
| | |
KM estimate 2 year RPFTc
| | |
75 %
| |
KM estimate 2 year OSTd
| | |
79 %
| |